Showing results (1151-1160 of 1,322) with videos related to

Sort By:
Pageof 133
Endocrine-Related Cancer|October 5, 2007
DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patientsY M H Jonkers, S M H Claessen, A Perren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Absolute quantification of [(11)C]docetaxel kinetics in lung cancer patients using positron emission tomographyAstrid A M van der Veldt, Mark Lubberink, Henri N Greuter, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 2021
Initiating Pancreatic Neuroendocrine Tumor (pNET) Screening in Young MEN1 Patients: Results From the DutchMEN Study GroupMirthe J Klein Haneveld, Mark J C van Treijen, Carolina R C Pieterman, et al.
Neuroendocrinology|January 4, 2005
Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotidePhilippe Ruszniewski, Sofia Ish-Shalom, Machteld Wymenga, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2021
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE studyNicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
The American Journal of Pathology|July 19, 2011
Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcomeDorian R A Swarts, Sandra M H Claessen, Yvonne M H Jonkers, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 2011
SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomasEsther Korpershoek, Judith Favier, José Gaal, et al.
BMC Genomics|June 5, 2008
The genome of the versatile nitrogen fixer Azorhizobium caulinodans ORS571Kyung-Bum Lee, Philippe De Backer, Toshihiro Aono, et al.
Clinical Pharmacology and Therapeutics|May 10, 2017
Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' DiseaseT S Plantinga, P Arts, G H Knarren, et al.
The Lancet. Oncology|March 1, 2020
Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 studyArthur J A T Braat, Rutger C G Bruijnen, Rob van Rooij, et al.
Pageof 133